L-asparaginase-induced antithrombin type I deficiency: implications for conformational diseases.
about
Crystal structure and allosteric regulation of the cytoplasmic Escherichia coli L-asparaginase IIdentification of antithrombin-modulating genes. Role of LARGE, a gene encoding a bifunctional glycosyltransferase, in the secretion of proteins?GCN2 is required to increase fibroblast growth factor 21 and maintain hepatic triglyceride homeostasis during asparaginase treatment.Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency.Asparaginase-associated toxicity in children with acute lymphoblastic leukemia.Control of post-translational modifications in antithrombin during murine post-natal development by miR-200aGeneral control nonderepressible 2 deletion predisposes to asparaginase-associated pancreatitis in mice.Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levelsThe eukaryotic initiation factor 2 kinase GCN2 protects against hepatotoxicity during asparaginase treatment.GCN2 protein kinase is required to activate amino acid deprivation responses in mice treated with the anti-cancer agent L-asparaginase.Antithrombin deficiency and its laboratory diagnosis.Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel.L-Asparaginase as potent anti-leukemic agent and its significance of having reduced glutaminase side activity for better treatment of acute lymphoblastic leukaemia.The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia.L-asparaginase and venous thromboembolism in acute lymphocytic leukemiaDesign and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase ActivityThe infective polymerization of conformationally unstable antithrombin mutants may play a role in the clinical severity of antithrombin deficiency.Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin.In vivo effects of hyperthermia on the functional and conformational characteristics of antithrombin.Genetic predisposition to fetal alcohol syndrome: association with congenital disorders of N-glycosylation.Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family
P2860
Q24681679-5ADCB3EE-B9D1-49FB-A088-CD4E52580AB6Q34738273-FAE98C59-E586-4E2E-A78B-E16136B1BF83Q35086484-9207682E-FF3F-48C8-BE17-848FC0CB724EQ35966475-B14C83F5-8513-491E-A01D-C19C6329A0CFQ36762608-4A08635D-BFC8-4008-B388-F3F416A7C887Q36908636-AF4655FF-99EE-48A0-A6A3-AA75917BAC3FQ37071811-6B094FC4-EA0B-4A72-81D1-70174E070B96Q37146081-F99EC731-E646-4E32-8F0E-974443F9E641Q37341948-6778B1C0-A571-41BE-94B0-D4364098D8F2Q37432106-83A4529C-8045-43C1-8FA9-28248C21E803Q37808223-85043A53-8085-490C-81AD-C1B169F26B15Q37914185-5AEE6745-B584-4B21-AE1F-8A3F14480AABQ38017602-3CC16B26-30DF-4139-B528-ADF02603A21CQ38055656-F65C5CE1-BBF3-4FFC-B817-359EFD91740DQ38566744-D8932DD5-E617-4FF9-9C8B-EBEDD52D1CD7Q38761096-CEF3C665-472E-4B48-826C-E78690BA4ED3Q39368580-C700A439-1FF0-405B-9E76-FB7DC78F42DDQ40025076-BBCB3968-63B5-4FEF-8A1A-56BBDDCC3053Q40451160-5DA9B519-9AAF-4552-9CE8-96AEA19FF169Q46854045-F07298BE-BAA4-40F5-AE28-DBE67E376AC7Q58764405-FDBA9F8E-DA1B-4493-8B26-BA184FB3FC36
P2860
L-asparaginase-induced antithrombin type I deficiency: implications for conformational diseases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
L-asparaginase-induced antithr ...... s for conformational diseases.
@en
type
label
L-asparaginase-induced antithr ...... s for conformational diseases.
@en
prefLabel
L-asparaginase-induced antithr ...... s for conformational diseases.
@en
P2093
P2860
P1476
L-asparaginase-induced antithr ...... ns for conformational diseases
@en
P2093
Antonia Miñano
Constantino Martínez
David Hernández-Espinosa
Elena Pérez-Ceballos
Inmaculada Heras
José L Fuster
P2860
P304
P356
10.2353/AJPATH.2006.051238
P407
P577
2006-07-01T00:00:00Z